Quick Takeaways
- Herve Hoppenot has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $31,711,818.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Herve Hoppenot
- Location
- Wilmington, DE
- Summary
- The estimated net worth of Herve Hoppenot is at least $31,711,818 dollars as of 06 Jan 2026. Herve Hoppenot is the Director of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $31.6M. Herve Hoppenot is the Director of BICYCLE THERAPEUTICS PLC and owns shares of BICYCLE THERAPEUTICS PLC (BCYC) stock worth about $110K.
- Signature
- /s/ Travis Thompson, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Herve Hoppenot and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: INCYTE CORP ($31,601,850).
- Past-year value change for that position: -$19,773,750.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Herve Hoppenot
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | Director | $31,601,850 | -$19,773,750 | -38% | 08 Dec 2025 |
| BCYC | BICYCLE THERAPEUTICS PLC | Director | $109,968 | 02 Jan 2026 | ||
| MAZE | Maze Therapeutics, Inc. | Director | 06 Oct 2025 |
Insider Transactions Reported by Herve Hoppenot:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.